JONATHAN SCOTT TREISMAN, M. D.

Plain English
This study looked at lymphoma patients and how financial issues affect their ability to get medical care. Between 1997 and 2018, nearly 10% of lymphoma patients reported delaying care because of costs, with higher rates among those aged 25 to 64 and the uninsured. Understanding these financial barriers is important because they can lead to worse health outcomes for patients. Who this helps: This helps lymphoma patients and their doctors.

Plain English
This study looked at how long patients with metastatic renal cell cancer (mRCC) survived after being treated with high dose interleukin-2 (HD IL-2). Among 810 patients, those considered at low risk lived an average of 63.3 months, while those at intermediate risk lived about 42.4 months, and those at high risk lived only 14 months. These findings show that patients with favorable risk benefit significantly from HD IL-2 treatment, suggesting it is an effective option for those eligible. Who this helps: This helps patients with metastatic renal cell cancer and their doctors in choosing effective treatment options.

Plain English
This study looked at multiple myeloma patients who were treated with two specific drugs, bortezomib and thalidomide, to see how their vitamin D levels affected nerve damage. Out of 111 patients, 42% had low vitamin D levels, and those with very low levels were more likely to experience severe nerve problems. Specifically, patients with vitamin D deficiency were more frequently affected by serious motor and sensory nerve issues. Who this helps: This research benefits multiple myeloma patients and their doctors by highlighting the importance of monitoring vitamin D levels during treatment.

Plain English
This study looked at how a protein complex called the exon junction complex (EJC) helps control the activity of transposable elements, which are DNA sequences that can move around in the genome, in fruit flies (Drosophila). The researchers found that a specific part of this complex, called RnpS1, is crucial for correctly processing a gene known as piwi; without RnpS1, an unnecessary section of this gene remained, which can lead to problems. This is important because it helps prevent unwanted genetic material from accumulating, which can affect the health and development of the organism. Who this helps: This helps researchers and scientists studying genetics and development in both fruit flies and humans.

Plain English
This study looked at how well a drug called plerixafor works for collecting blood stem cells in myeloma patients who have severe kidney problems. Out of 21 patients, 20 were able to successfully collect enough cells for a transplant, with most achieving a good cell dose after one to three procedures. Importantly, 12 of these patients are still alive without their disease getting worse, and some even improved their kidney function afterward. Who this helps: This benefits myeloma patients with severe kidney failure by providing a viable option for stem cell collection needed for treatment.

Plain English
This study looked at how well a method called flow cytometry can identify remaining melanoma cells in cultures of tumor-infiltrating lymphocytes (TIL), which are being tested as a treatment for advanced melanoma. The researchers found that flow cytometry accurately detected tumor cells in all tested samples and showed that after treatment with IL-2, there was a significant reduction in melanoma cells—only 2 out of 12 samples still contained tumor cells, and none were found in the further-treated samples. This is important because it provides a more precise method for ensuring that TIL therapies are pure and effective before they are given to patients. Who this helps: Patients undergoing treatment for metastatic melanoma.

Plain English
This study looked at the effects of combining a melanoma vaccine with a treatment called interleukin-2 in patients with advanced melanoma. The results showed that only 16% of patients receiving both treatments responded positively, compared to just 6% in those receiving interleukin-2 alone; additionally, patients receiving the combination treatment lived longer without the cancer progressing (2.2 months vs. 1.6 months). These findings are important because they suggest that the combination treatment could be more effective in improving outcomes for patients with advanced melanoma. Who this helps: This helps patients with advanced melanoma.

Plain English
This paper examines how patients with high-risk and advanced skin melanoma are treated, focusing on the effectiveness of immunotherapy and targeted therapies. It highlights the use of interferon treatment and explores new treatments that are being tested, which could lead to better outcomes for patients. This research is important because it shows promise for improving survival rates and quality of life for those affected by this aggressive type of cancer. Who this helps: Patients with high-risk and advanced skin melanoma.

Plain English
This study looked at a small molecule called miR-8 in fruit flies and its effects on a protein called atrophin, which is important for brain health. The researchers found that when miR-8 was mutated, atrophin levels became too high, leading to more brain cell death and negative behavior changes in the fruit flies. This research is important because it shows that maintaining the right amount of atrophin is crucial for brain health and could have implications for understanding similar issues in humans, especially in neurodegenerative diseases. Who this helps: Patients with neurodegenerative disorders and their doctors.

Plain English
This study looked at ways to improve the effectiveness of a genetic technique used on human immune cells called lymphocytes, which can help treat diseases like cancer. Researchers modified a viral vector and found that adding specific elements increased the amount of targeted receptors in lymphocytes. Specifically, they saw a significant boost in the immune response, with cells becoming much better at killing colon cancer cells when the right modifications were made. Who this helps: This benefits cancer patients needing improved immune therapies.

Plain English
The researchers studied two genes in fruit flies that are similar to human genes important for eye development. They found that mutations in these genes led to problems in the development of eye and antenna structures, causing the cells to express the wrong genes and not develop properly. Specifically, the mutations did not affect cell growth but disrupted normal signaling, indicating that these genes play a crucial role in organizing developmental signals. Who this helps: This research benefits geneticists and developmental biologists who study eye and antenna development.

Plain English
This study looked at how two signals, DPP and EGF, work together to control the boundary between different types of cells in fruit fly (Drosophila) ovaries. The researchers found that when DPP is present, it reduces the activity of a protein called bunched, which normally helps form the outer layer of the eggshell, while EGF increases bunched activity. Specifically, lowering bunched activity caused the eggshell's outer layer to expand and lose its defined shape. Who this helps: This research benefits scientists and medical researchers studying cell signaling and development in animals.

Plain English
This study looked at a new way to help the immune system fight colon cancer by modifying T cells, which are a type of immune cell. Researchers created special receptors that help T cells recognize a specific protein associated with colon cancer, called EGP40. They found that T cells modified with these receptors could effectively target and kill colon cancer cells, specifically the ones expressing EGP40, showing promising results for treatment. Who this helps: This research benefits patients with colon cancer by potentially providing new treatment options.

Plain English
This study looked at how a protein called Misshapen (Msn) interacts with another protein, DTRAF1, to activate a pathway essential for cell growth and development in fruit flies (Drosophila). The researchers found that when Msn and DTRAF1 work together, they effectively activate a specific signaling pathway called JNK, which is crucial for proper embryonic development. Understanding this interaction is important because disruption of the JNK pathway can lead to serious developmental issues, like embryo death. Who this helps: This helps researchers and potentially patients with developmental disorders related to JNK pathway disruptions.

Plain English
This study looked at a way to enhance the survival and effectiveness of T cells used in cancer treatment by making them produce their own interleukin-2 (IL-2). Researchers found that T cells modified to produce IL-2 themselves were able to grow and multiply without needing extra IL-2 from outside sources, while still being responsive to cancer targets and causing no tumor growth when injected into mice. This is important because it could mean a safer and more effective method for using T cells in immunotherapy without the harmful side effects of long-term IL-2 treatments. Who this helps: Patients undergoing cancer treatments that use T cell therapies.

Plain English
This study looked at how T cells, which are a type of immune cell, can be changed to better target and attack specific types of cancer cells. Researchers found that T cells specially modified with a chimeric receptor gene (called MOv-gamma) significantly increased survival rates in mice with ovarian cancer. For instance, mice with these modified T cells had notably fewer lung tumors compared to those treated with non-modified T cells or other controls. Who this helps: This research benefits cancer patients, particularly those with ovarian cancer and possibly other types of tumors in the future.

Plain English
This study looked at a new way to grow immune cells called T lymphocytes, which help fight tumors, without needing the potentially harmful substance interleukin-2 (IL-2). Researchers created special receptors that allow these cells to use a safer substance called erythropoietin (Epo) for growth and found that these modified cells can grow when Epo is present. This is important because it could lead to safer cancer treatments by reducing the side effects associated with high doses of IL-2. Who this helps: This helps cancer patients undergoing immunotherapy.

Plain English
This study looked at a gene called MAGE-1, which produces a protein that helps the immune system recognize melanoma, a type of skin cancer. Researchers found that a drug called 5-aza-2'-deoxycytidine (DAC) can boost the production of MAGE-1 in melanoma cells, allowing the immune system to target these cancer cells more effectively. In experiments, this boost lasted for two weeks after the drug was removed, indicating a strong and lasting effect. Who this helps: This benefits patients with melanoma by potentially improving their immune response against the cancer.

Plain English
This study looked at how retinoic acid (RA) affects a type of immune cell called tumor-infiltrating lymphocytes (TIL) that have been genetically modified to produce a protein called tumor necrosis factor (TNF), which helps fight cancer. The researchers found that treating these cells with RA increased their TNF production by about two times, lasting for 3 to 6 days after the treatment stopped. This is important because it shows that RA can enhance the effectiveness of these immune cells in cancer therapies. Who this helps: This benefits cancer patients undergoing personalized immunotherapy.

Plain English
This research looked at how two proteins, hunchback (hb) and bicoid (bcd), work together to help shape the front end of fruit fly embryos. The scientists found that without hb, bcd doesn't function properly, leading to disorderly embryos that can't develop correctly. Their results show that both proteins need to work together to create the gradient that determines how the embryo grows, emphasizing that bcd alone isn't enough. Who this helps: This helps researchers and biologists studying embryonic development and gene interactions.

Plain English
Researchers studied how to make certain immune cells, called tumor-infiltrating lymphocytes (TIL), better at targeting and destroying ovarian cancer cells. They found that by using special genes to modify these TIL, the immune cells could effectively kill cancer cells from a human ovarian cancer line, IGROV-1, and also produce important signaling molecules. This is significant because it could lead to new treatments for ovarian cancer, improving outcomes for patients. Who this helps: Patients with ovarian cancer.

Plain English
This study looked at how a protein called bicoid, which helps determine the front part of fruit fly (Drosophila) embryos, is controlled by another protein called torso. Researchers found that while bicoid activates important genes, the torso protein can shut it down through a process involving another protein, D-raf. Specifically, they discovered that this shutdown occurs when torso adds a chemical tag to bicoid, but other proteins thought to be involved are not necessary for this process. Why it matters: Understanding how these proteins interact is crucial for grasping how embryo development is regulated, which could have broader implications in biology and medicine. Who this helps: This helps researchers studying development and genetic regulation.

Plain English
This study looked at a specific protein structure called the homeodomain (HD), which plays a key role in how genes are turned on and off during the development of organisms. Researchers found that while the HD has similarities to another protein structure from bacteria, it interacts differently with DNA, allowing for varied functions in gene regulation. This discovery matters because it helps us understand how complex genetic functions can arise from relatively simple protein structures. Who this helps: This helps researchers and doctors who are studying genetic diseases and developmental disorders.

Plain English
This study focused on a specific DNA sequence known as the paired box in certain genes. Researchers found that the paired box allows a protein called Prd to bind to DNA in a unique way, separate from another part of the protein known as the homeo domain. When a mutation occurred in the paired box, it prevented the Prd protein from correctly binding to its target, which is linked to a skeletal problem seen in mice. Who this helps: This research benefits geneticists and doctors studying developmental disorders and genetic mutations.

Plain English
This study looked at how T cells, a type of immune cell, respond to a specific activation process in patients with systemic lupus erythematosus (SLE). Researchers found that T cells from 57 SLE patients responded much less effectively to a test that used anti-CD2 antibodies compared to 32 healthy individuals, with a statistically significant difference (p < 0.0001). This matters because it suggests that SLE patients may have fundamental issues with their T cells that can impact their immune response, even if they are not currently experiencing active disease. Who this helps: This research benefits patients with systemic lupus erythematosus by providing insight into their immune system challenges.

Plain English
This study looked at how interleukin 4 (IL-4) affects the growth of immune cells, called lymphocytes, taken from cancer patients who had received interleukin 2 (IL-2) therapy. The researchers found that while IL-4 did not help normal immune cells grow, it boosted the growth of lymphocytes from cancer patients, particularly when combined with IL-2 or certain antibodies. Specifically, IL-4 enhanced the proliferation response in 6 out of 9 patients when using high doses of IL-2, indicating that combining these treatments may improve cancer therapies. Who this helps: This research benefits cancer patients undergoing immunotherapy.

Plain English
This study looked at two genes, hunchback and Krüppel, in fruit flies and how they interact to control gene expression during early development. The researchers found that the protein from the Krüppel gene binds to a specific DNA sequence, while the hunchback protein binds to another sequence, showing how they work together to regulate the hunchback gene. Understanding these interactions is important because it helps explain how early development is organized in living organisms. Who this helps: This benefits researchers studying gene regulation and development in various organisms.

Plain English
Researchers studied how a specific part of a protein called the homeodomain, which is important for gene regulation in fruit flies (Drosophila), interacts with DNA. They discovered that just changing one building block (amino acid) in the protein Prd can change which genes it can bind to, making it behave like two other proteins (Ftz and Bcd). This finding is significant because it reveals that the rules governing how these proteins recognize DNA are different from those in simpler organisms, providing new insights into gene regulation. Who this helps: This helps scientists and researchers understanding genetic regulation and development.

Plain English
This study looked at an adult woman with Turner syndrome who had swelling in her limbs and fluid buildup in her abdomen. The researchers found that she also had unusual blood vessel structures, including a right-sided aortic arch. They discovered that a certain treatment, called a peritoneo-venous shunt, helped relieve her symptoms. Who this helps: This benefits patients with Turner syndrome and their doctors by providing insights into uncommon complications and potential treatments.

Plain English
This study looked at a substance called ethchlorvynol and its breakdown products to understand their potential harmful effects on humans. Researchers found a specific metabolite that was present in both nonfatal and fatal poisonings, and while some of its compounds were not directly mutagenic (able to cause genetic mutations), they were toxic to certain bacteria. These findings highlight the need to better understand the risks associated with this drug and its metabolites, as they could pose serious health risks. Who this helps: This helps patients who use ethchlorvynol and healthcare professionals managing their prescriptions.